INIFY Laboratories AB

OSL • Healthcare • Diagnostics & Research • Quote as of 10/29/2026

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeOSL

Market Capitalization591.11 mln

Float107 mln

Earnings Date10/28/2026

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-2.39

Borderline

Relative Strength

9 / 100

Severely lagging

Pre-Tax Margin

-333%

Severely loss-making

ROE

-63.27

Deeply negative

Altman Z-Score

18.72

Exceptional

Business Description

INIFY Laboratories AB is a Stockholm-based company founded in 2021 that specializes in detecting prostate cancer for patients in Sweden.

Key Fundamentals

EPS-0.92

ROE-63.27

ROIC-105

ROA-53.49

EBITDA, mln-71.99

EV / EBITDA-5.32

EV / EBIT-4.64

Revenue, mln24.82

EV / Revenue15.43

Quote Details

Last 5.50

Change 0 (0%)

Open 5.55

Volume 21,316

Turnover 117,238

Average Volume 5,094.86

Financial Ratios

Pre-Tax Profit Margin-333

Current Ratio6.90

Price / Book3.29

Price / Tangible Book3.31

Price / Sales16.29

Financial Strength

Altman Z-Score18.72

Piotroski F-Score 4 / 9

Beneish M-Score-2.39

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-5.98%	9 / 100
1 Month	-8.33%	21 / 100
2 Months	-29.49%	6 / 100
6 Months	37.5%	93 / 100
1 Year	-11.29%	30 / 100